Gilead Sciences Actual
News for Gilead Sciences Actual
/PRNewswire/ --MOMENTUM at EMC WORLD -- News Highlights: New solutions leverage EMC Documentum platform to help customers in Energy, Life Sciences... ...
http://in.advfn.com/p.php?pid=nmona&article=57459226- Product Sales of $2.39 billion, Up 8 percent over First Quarter 2012 - - Total Revenues of $2.53 billion, Up 11 percent over First Quarter 2012 -... ...
http://www.asianhhm.com/press/pressrelease_archives.asp?PID=4094-- Company Plans to Initiate Phase 3 Study Evaluating Eight and 12 Weeks of Therapy with Sofosbuvir and Ledipasvir for the Treatment of Chronic... ...
http://www.asianhhm.com/press/pressrelease_archives.asp?PID=4079(GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) announced today that trading of GW Pharmaceuticals (Nasdaq:GWPH), a biopharmaceutical... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=308655FOSTER CITY, Calif. Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the company has received Complete Response Letters from the U.S. Food... ...
http://www.asianhhm.com/press/pressrelease_archives.asp?PID=3936Related Tags
Top Coverage News
© 2013 Rediff.com - Investors - Advertise - Disclaimer - Privacy - Careers - Feedback | Terms of use | India Abroad weekly